Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $1.92 Million - $2.2 Million
-14,317 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $385,381 - $478,150
-2,920 Reduced 16.94%
14,317 $2.32 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $4,619 - $5,844
43 Added 0.25%
17,237 $2.33 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $427,089 - $484,810
4,014 Added 30.46%
17,194 $1.86 Million
Q2 2021

Aug 06, 2021

BUY
$105.21 - $117.21 $458,610 - $510,918
4,359 Added 49.42%
13,180 $1.49 Million
Q1 2021

May 12, 2021

SELL
$102.3 - $112.62 $224,957 - $247,651
-2,199 Reduced 19.95%
8,821 $955,000
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $177,238 - $239,291
2,202 Added 24.97%
11,020 $1.18 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $31,700 - $37,206
-369 Reduced 4.02%
8,818 $772,000
Q2 2020

Aug 06, 2020

SELL
$73.37 - $98.18 $34,924 - $46,733
-476 Reduced 4.93%
9,187 $902,000
Q1 2020

May 12, 2020

SELL
$64.5 - $97.79 $2,902 - $4,400
-45 Reduced 0.46%
9,663 $736,000
Q4 2019

Jan 31, 2020

BUY
$72.13 - $90.25 $27,625 - $34,565
383 Added 4.11%
9,708 $860,000
Q3 2019

Nov 08, 2019

SELL
$62.98 - $75.72 $288,259 - $346,570
-4,577 Reduced 32.92%
9,325 $706,000
Q2 2019

Aug 06, 2019

BUY
$65.7 - $83.98 $318,185 - $406,715
4,843 Added 53.46%
13,902 $1.01 Million
Q1 2019

Apr 29, 2019

SELL
$77.14 - $90.79 $1,388 - $1,634
-18 Reduced 0.2%
9,059 $730,000
Q4 2018

Feb 07, 2019

BUY
$77.85 - $96.01 $4,359 - $5,376
56 Added 0.62%
9,077 $837,000
Q3 2018

Nov 20, 2018

BUY
$88.91 - $98.84 $88 - $98
1 Added 0.01%
9,021 $853,000
Q2 2018

Aug 09, 2018

SELL
$89.78 - $106.23 $149,932 - $177,404
-1,670 Reduced 15.62%
9,020 $836,000
Q1 2018

May 14, 2018

BUY
$92.01 - $123.21 $6,624 - $8,871
72 Added 0.68%
10,690 $1.01 Million
Q4 2017

Feb 02, 2018

BUY
$89.56 - $98.21 $950,948 - $1.04 Million
10,618
10,618 $1.03 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Meristem Family Wealth, LLC Portfolio

Follow Meristem Family Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meristem Family Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meristem Family Wealth, LLC with notifications on news.